SpringWorks Therapeutics, Inc.
SWTX
$37.06
-$0.86-2.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 307.99M | 376.62M | 383.89M | 436.58M | 479.20M |
| Total Receivables | 46.24M | 32.97M | 24.50M | 15.53M | 5.93M |
| Inventory | 10.21M | 9.83M | 7.72M | 5.22M | 3.10M |
| Prepaid Expenses | 16.03M | 15.69M | 15.22M | 14.47M | 12.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 380.47M | 435.11M | 431.32M | 471.80M | 500.91M |
|
|
|||||
| Total Current Assets | 380.47M | 435.11M | 431.32M | 471.80M | 500.91M |
| Net Property, Plant & Equipment | 26.66M | 25.36M | 24.57M | 24.08M | 24.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 15.56M | -- | -- | -- | 11.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.47M | 21.32M | 16.00M | 15.39M | 4.25M |
| Total Assets | 587.28M | 608.88M | 617.33M | 656.83M | 725.79M |
|
|
|||||
| Total Accounts Payable | 12.25M | 9.65M | 7.89M | 7.01M | 7.40M |
| Total Accrued Expenses | 86.01M | 59.73M | 45.65M | 56.27M | 65.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.73M | 1.23M | 958.00K | 981.00K | 1.06M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 4.65M | 4.14M |
| Total Other Current Liabilities | -- | -- | -- | 4.65M | 4.14M |
| Total Current Liabilities | 99.99M | 70.61M | 54.50M | 68.92M | 78.17M |
|
|
|||||
| Total Current Liabilities | 99.99M | 70.61M | 54.50M | 68.92M | 78.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.18M | 5.68M | 6.10M | 5.58M | 6.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 14.89M | 15.40M |
| Total Liabilities | 106.17M | 76.30M | 60.60M | 89.39M | 99.57M |
|
|
|||||
| Common Stock & APIC | 1.65B | 1.62B | 1.59B | 1.56B | 1.52B |
| Retained Earnings | -1.15B | -1.08B | -1.02B | -982.42M | -895.03M |
| Treasury Stock & Other | -12.28M | -10.45M | -12.08M | -10.75M | -2.95M |
| Total Common Equity | 481.10M | 532.58M | 556.73M | 567.44M | 626.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 481.10M | 532.58M | 556.73M | 567.44M | 626.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 481.10M | 532.58M | 556.73M | 567.44M | 626.22M |
|
|
|||||